↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"

A　B　C　D　E　F　G　H　 I 　J　K　L　M　N　O　P　Q　R　S　T　U　V　W　X　Y　Z　other

106 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名（臨床試験情報から抽出）   DrugBank   KEGG DRUG *   KEGG GENES *   KEGG PATHWAY   指定難病告示番号 * 
 1   (r)-(1-(4-fluorophenyl)-6-((1-methyl-1h-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1h-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone   Pyrazole   -   -   -   1件:
75 
 2   17beta-hydroxy-11beta-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one   -   -   -   -   1件:
75 
 3   17ß-hydroxy-11ß-(4-dimethylaminophenyl)17a-(prop-1-ynyl)estra-4,9-dien-3-one   -   -   -   -   1件:
75 
 4   18f-dopa   -   -   -   -   2件:
6,
75 
 5   1h-pyrazol   Pyrazole   -   -   -   2件:
46,
75 
 6   Abiraterone   Abiraterone   D09701   -   -   2件:
75,
81 
 7   Abiraterone acetate   Abiraterone   D09701   -   -   2件:
75,
81 
 8   Acetate   Acetate   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299 
 9   Acthrel   Corticorelin ovine triflutate   D03592   2件: CRHR1, CRHR2   3件: Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction   1件:
75 
 10   Aspartate   Aspartic acid   D00013   -   -   3件:
13,
75,
299 
 11   Atr-101   -   -   -   -   2件:
75,
81 
 12   Azd4017   Azd4017   -   -   -   1件:
75 
 13   Azd4017 and prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
75 
 14   Bexarotene   Bexarotene   D03106   3件: RXRA, RXRB, RXRG   15件: Adipocytokine signaling pathway, Bile secretion, Gastric cancer, Hepatitis C, Non-alcoholic fatty liver disease (NAFLD), Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer   2件:
13,
75 
 15   Cabergoline   Cabergoline   D00987   2件: DRD2, PRL   12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway   3件:
6,
74,
75 
 16   Calcium   Calcium   -   -   -   24件:
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299 
 17   Calcium carbonate   Calcium carbonate   D00932, D10802   -   -   7件:
13,
19,
46,
75,
96,
235,
299 
 18   Carbonate   Carbonate ion   -   -   -   10件:
2,
13,
17,
19,
46,
75,
96,
127,
235,
299 
 19   Cor-003   -   -   -   -   1件:
75 
 20   Cort125134   Relacorilant   D11336   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
75 
 21   Corticotropin   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   7件:
2,
13,
46,
75,
78,
84,
222 
 22   Corticotropin-releasing hormone   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
75 
 23   Cushing's syndrome confirmation   -   -   -   -   1件:
75 
 24   Cyclo((diaminoethyl-carbamate)hypro-phg-(d)trp-lys-tyr(bzl)-phe) di-aspartate   Aspartic acid   D00013   -   -   1件:
75 
 25   Ddavp   Desmopressin   D00291, D02235   2件: AVPR2, F8   4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption   2件:
75,
288 
 26   Dexamethasone   Dexamethasone   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   20件:
13,
16,
28,
35,
46,
53,
63,
65,
70,
74,
75,
81,
83,
84,
90,
96,
97,
222,
296,
299 
 27   Dostinex   Cabergoline   D00987   2件: DRD2, PRL   12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway   1件:
75 
 28   Dotatate   Dotatate   -   -   -   3件:
41,
75,
84 
 29   Dotatate pet-ct   Dotatate   -   -   -   1件:
75 
 30   Eplerenone   Eplerenone   D01115   1件: NR3C2   1件: Aldosterone-regulated sodium reabsorption   3件:
75,
113,
215 
 31   F-dopa pet ct   -   -   -   -   1件:
75 
 32   Gefitinib   Gefitinib   D01977   1件: EGFR   45件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis   1件:
75 
 33   Genotropin 12mg   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   3件:
74,
75,
78 
 34   Genotropin 5.3mg   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   3件:
74,
75,
78 
 35   Genotropin miniqu   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   3件:
74,
75,
78 
 36   Genotropin miniquick 0.2mg   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   3件:
74,
75,
78 
 37   Genotropin miniquick 0.4mg   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   3件:
74,
75,
78 
 38   Genotropin miniquick 0.6mg   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   3件:
74,
75,
78 
 39   Genotropin miniquick 0.8mg   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   3件:
74,
75,
78 
 40   Genotropin miniquick 1.0mg   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   3件:
74,
75,
78 
 41   Genotropin miniquick 1.2mg   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   3件:
74,
75,
78 
 42   Glucophage (metformin)   Metformin   D00944, D04966   2件: PRKAA1, PRKAA2   19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy (HCM), Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease (NAFLD), Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway   2件:
46,
75 
 43   Hra052015   -   -   -   -   1件:
75 
 44   Hra052015 (mifepristone)   Mifepristone   D00585   2件: NR3C1, PGR   5件: Breast cancer, Estrogen signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, Progesterone-mediated oocyte maturation   1件:
75 
 45   Hydrocortisone   Hydrocortisone   D00088   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   8件:
6,
53,
75,
78,
81,
83,
97,
299 
 46   Insulin   -   -   -   -   5件:
13,
46,
75,
78,
299 
 47   Ketoconazole   Ketoconazole   D00351   1件: CYP17A1   6件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis   3件:
8,
13,
75 
 48   L0006cp03a   -   -   -   -   1件:
75 
 49   Lapatinib   Lapatinib   D04024, D08108   2件: EGFR, ERBB2   47件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Platinum drug resistance, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction   3件:
34,
74,
75 
 50   Lci699   -   -   -   -   1件:
75 
 51   Levoketoconazole   Levoketoconazole   D10950   -   -   1件:
75 
 52   Levoketozonazole   -   -   -   -   1件:
75 
 53   Liraglutide   Liraglutide   D06404   1件: GLP1R   3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway   3件:
6,
75,
193 
 54   Matyrapone   -   -   -   -   1件:
75 
 55   Metformin   Metformin   D00944, D04966   2件: PRKAA1, PRKAA2   19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy (HCM), Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease (NAFLD), Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway   16件:
6,
13,
46,
49,
67,
75,
77,
81,
86,
113,
158,
206,
225,
233,
265,
285 
 56   Methionine   Methionine   D00019, D04983   -   -   6件:
34,
75,
84,
93,
229,
300 
 57   Metopirone 250 mg capsules/cormeto   Metyrapone   D00410, D05019   1件: CYP11B1   4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis   1件:
75 
 58   Metyrapone   Metyrapone   D00410, D05019   1件: CYP11B1   4件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis   2件:
75,
193 
 59   Mifedren   -   -   -   -   1件:
75 
 60   Mifepristone   Mifepristone   D00585   2件: NR3C1, PGR   5件: Breast cancer, Estrogen signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, Progesterone-mediated oocyte maturation   1件:
75 
 61   Nizoral   Ketoconazole   D00351   1件: CYP17A1   6件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis   1件:
75 
 62   Octreotide   Octreotide   D00442, D06495   1件: SSTR2   4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway   7件:
67,
75,
84,
85,
89,
193,
227 
 63   Orocal   -   -   -   -   1件:
75 
 64   Osilodrostat   Osilodrostat   D11061   1件: CYP11B2   3件: Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis   1件:
75 
 65   Osilodrostat 10mg   Osilodrostat   D11061   1件: CYP11B2   3件: Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis   1件:
75 
 66   Osilodrostat 1mg   Osilodrostat   D11061   1件: CYP11B2   3件: Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis   1件:
75 
 67   Osilodrostat 20mg   Osilodrostat   D11061   1件: CYP11B2   3件: Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis   1件:
75 
 68   Osilodrostat 5mg   Osilodrostat   D11061   1件: CYP11B2   3件: Aldosterone synthesis and secretion, Metabolic pathways, Steroid hormone biosynthesis   1件:
75 
 69   Ossein hydroxyapatite   -   -   -   -   1件:
75 
 70   Osteopor   -   -   -   -   1件:
75 
 71   Ovine corticotropin-releasing hormone (ocrh)   Corticotropin   D00146   1件: MC2R   5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
75 
 72   Pasireotide   Pasireotide   D10147   4件: SSTR1, SSTR2, SSTR3, SSTR5   4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway   3件:
67,
74,
75 
 73   Pasireotide 0.6 mg/ml   Pasireotide   D10147   4件: SSTR1, SSTR2, SSTR3, SSTR5   4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
75 
 74   Pasireotide diaspartate   Pasireotide   D10147   4件: SSTR1, SSTR2, SSTR3, SSTR5   4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
75 
 75   Pasireotide lar   Pasireotide   D10147   4件: SSTR1, SSTR2, SSTR3, SSTR5   4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway   2件:
67,
75 
 76   Pasireotide pamoate   Pasireotide   D10147   4件: SSTR1, SSTR2, SSTR3, SSTR5   4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
75 
 77   Pasireotide s.c.   Pasireotide   D10147   4件: SSTR1, SSTR2, SSTR3, SSTR5   4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
75 
 78   Pasireotide with or without cabergoline   Cabergoline, Pasireotide   D00987, D10147   6件: DRD2, PRL, SSTR1, SSTR2, SSTR3, SSTR5   14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway   1件:
75 
 79   Pentetreotide   Pentetreotide   D01859   -   -   1件:
75 
 80   Prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   38件:
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300 
 81   R-roscovitine   Seliciclib   -   -   -   1件:
75 
 82   Relacorilant   Relacorilant   D11336   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
75 
 83   Rosiglitazone   Rosiglitazone   D00596, D08491   1件: PPARG   9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer   5件:
46,
75,
97,
222,
265 
 84   Rosiglitazone maleate   Rosiglitazone   D00596, D08491   1件: PPARG   9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer   3件:
46,
75,
265 
 85   Rvg 08938   -   -   -   -   1件:
75 
 86   Rvg 15375   -   -   -   -   1件:
75 
 87   Rvg 18236   -   -   -   -   2件:
75,
227 
 88   Seliciclib   Seliciclib   -   -   -   2件:
75,
299 
 89   Signifor   Pasireotide   D10147   4件: SSTR1, SSTR2, SSTR3, SSTR5   4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
75 
 90   Sitagliptin   Sitagliptin   D08516   1件: DPP4   1件: Protein digestion and absorption   3件:
75,
233,
299 
 91   Som230   -   -   -   -   2件:
74,
75 
 92   Som230 300µg   -   -   -   -   1件:
75 
 93   Som230 600µg   -   -   -   -   1件:
75 
 94   Som230 900µg   -   -   -   -   1件:
75 
 95   Som230 lar 10 mg   -   -   -   -   1件:
75 
 96   Som230 lar 30 mg   -   -   -   -   1件:
75 
 97   Som230 lar, 20 mg   -   -   -   -   1件:
75 
 98   Som230 s.c.   -   -   -   -   1件:
75 
 99   Som230, 300micrograms   -   -   -   -   1件:
75 
 100   Som230, 600 micrograms   -   -   -   -   1件:
75 
 101   Som230, 900 micrograms   -   -   -   -   1件:
75 
 102   Som230b   -   -   -   -   1件:
75 
 103   Somatropin   Somatotropin   D02691   1件: GHR   5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway   15件:
2,
3,
19,
46,
74,
75,
78,
96,
113,
193,
195,
265,
274,
276,
299 
 104   Tadalafil   Tadalafil   D02008   1件: PDE5A   3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway   6件:
6,
51,
75,
84,
86,
113 
 105   Tretinoin   Tretinoin   D00094   3件: PML, RARA, RARB   12件: Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis   2件:
2,
75 
 106   Valsartan   Valsartan   D00400   1件: AGTR1   14件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway   6件:
57,
58,
66,
75,
218,
222 

先頭へ